eISSN: 1689-3530
ISSN: 0867-4361
Alcoholism and Drug Addiction/Alkoholizm i Narkomania
Bieżący numer Archiwum Online first O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
vol. 33
Poleć ten artykuł:
Artykuł oryginalny

Prognozowanie trendów hospitalizacji z powodu zatruć narkotykami w Semnan w Iranie do 2021 roku: modelowanie szeregów czasowych

Mahmood Moosazadeh
Mahdi Afshari
Somayeh Rezaie
Zahra Sahraie
Masumeh Ghazanfarpour
Masoudeh Babakhanian

Gastrointestinal Cancer Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
Department of Community Medicine, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran
School of Nursing and Midwifery, Shahroud University of Medical Science, Shahroud, Iran
Bahar Hospital, Shahroud University of Medical Science, Shahroud, Iran
Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran
Social Determinants of Health Research Center, Semnan University of Medical Sciences and Health Services, Semnan, Iran
Alcohol Drug Addict 2020; 33 (2): 151-160
Data publikacji online: 2020/10/13
Plik artykułu:
- AIN-3-Babakhanian.pdf  [0.36 MB]
Pobierz cytowanie
Metryki PlumX:


Epidemiologic studies have included illegal drug use as one of the four critical global crises [1]. Iran has been geographically located in the opium export belt. Illegal drug use is considered the main social and health concern in Iran with opium products the most commonly used substances that are also the main cause of poisoning [2, 3]. Frequent use of opium and stimulants can lead to adverse consequences and contribute to approximately two-third of suicides [4, 5]. There is evidence of an increasing hospital referrals rate for patients with alcohol and opium poisoning in recent years. In some cases poisonings are result of consumption of more than one substance or of illegal additives like lead [2].
According to a national survey conducted in Iran with use of the Network Scale Up method, the prevalence of at least one-time alcohol consumption in the previous year among people 15-year-old or more and also men aged between 18 and 30 were estimated as of 2.31% and 7% respectively. In addition, alcohol consumption among men was approximately eight times higher compared to females [6]. Another study carried out among Iranian high school students showed higher rates of illegal drug use among boys than girls. The lifetime rate of alcohol use as well as opium use were 9.9% and 1.2-8.6% respectively [7]. A study conducted in Southwest of Iran showed that tramadol (69.3%), opium (27.3%) and heroin (2.7%) were major sources of opioid overdosing events [8]. Another national study showed increases in the hospitalisation rates due to alcohol overdose (25%), drug overdose (55%) and combined drug-alcohol overdose (76%) during 1999-2008 [9]. Considering the high burden and costs of dependence, suicide and other outcomes of drug abuse, reducing the prevalence of any hazardous consumption of alcohol and the use of opium and other illegal stimulants can contribute to control of mortality and morbidity within the communities [10].
Forecasting the increasing or decreasing trend of patients with drug poisoning referred to the hospitals can provide suitable information for policymaking and implementation of intervention strategies. Since there was not enough information regarding these trends, we aimed to investigate the trend of patients with opium, stimulants and alcohol poisoning referrals to Semnan (a province in north of Iran) hospitals during 2011-2015 and forecast this trend up to 2021.

Material and methods

In this longitudinal study, Box & Jenkins model (ARIMA model) was applied for forecasting the drug/alcohol poisoning incident cases. At first, the protocol of the study was approved in the ethical review board of Semnan University of Medical Sciences, Semnan Iran (Ethical code: IR.SEMUMS.REC.1396.71). Next, all information was collected from the patients’ documents of hospitals of Semnan Province. This information was electronically available by diagnostic codes (ICD-10) during 2011-2015 in the medical records units of the hospitals. Counts of following causes were included into the study: acute alcohol poisoning (ethanol, methanol), poisoning due to overdose of opium, of stimulants (cocaine, amphetamine), poisoning with mixture of opiates, tramadol overdose and methadone poisoning (see codes in Tables I and II) [11].
Time variable in this study was each of the months during the study period. Sampling was performed by census method. The number of poisoning cases in each month during formed monthly time series in period 2011-2015 was determined. As a result 60 time points were analysed. Graphing the data time series and describing the frequency of patients with poisoning, the structure of this time series were investigated. After data processing for designing the stationary time series and more detail investigation of this assumption using Dickey-Fuller test, the parameters of model were determined using ACF (auto-correlation function) and PACF (partial auto-correlation function) graphs. To investigate the details of the time series parameters like trend, seasonal effect and random component, the time series was decomposed using moving average method. Using Akaike information criterion (AIC) statistics for suggested models (model with the lowest amount of AIC), ARIMA (0, 1, 1) was selected as the choice with the best fit. Finally, the frequency of referrals of patients with poisoning up to 2021 was predicted using ARIMA (0, 1, 1). The results was analysed using R 3.4.3 (forecast and tseries package) software.


The frequency of patients referrals to the studied hospitals differed from 400 in 2011 to 735 in 2015. The maximum referral rates were in January 2011 (56 cases), October 2012 (43), March 2013 (59), April 2014 (66) and January 2015 (80). The minimum rates were in March 2011 (12 cases), July 2012 (25), October 2013 (34), July/December 2014 (41) and March 2015 (46). The time series investigations showed a linear trend without any regular seasonal effect, i.e. incidence of poisoning did not have any seasonal pattern. The time series graph of the frequency of referrals of patients with poisoning to the hospitals of Semnan province is illustrated in Figure 1.
The box plots (Figure 2) of the frequency of referrals of patients with poisoning to the hospitals show the highest and lowest dispersion of referral data for August and October respectively. Also, there was no visible trend or seasonality in consecutive months. In the first half of the year in the Persian calendar1 March-September, all data have positive skewness indicating that the median number of patients was lower than the mean. This is the case for October, November and February in the second half of the year. The details of the time series parameters like trend, seasonal effect and random component, were mentioned in Figure 3. This showed that the time series has an increasing trend which can affect its static assumption. Figure 4 shows the decomposition of the time series using logarithmic conversion and first degree differential operator. Following this process, the increasing trend was removed and changed to static time series. Based on Dickey-Fuller test, the null hypothesis was rejected and the static assumption of the transformed data was approved (Dickey-Fuller: –12.572, p value: 0.01).
ACF and PACF graphs were used (Figures 5 and 6) to determine the degree of moving average and autoregression. ACF graph shows that the first and second observations were out of the mean range. Therefore MA (1) and MA (2) models have the best fit. Moreover, PACF graph shows that the deviation was just for the first observation, indicating that the AR (1) is the best model. Totally, ACF and PACF graphs revealed the usefulness of the ARIMA model regarding goodness of fit. Figures 5, 6 and 7 demonstrate that ARIMA (0, 1, 1), ARIMA (1, 1, 1) and ARIMA (1, 1, 2) seem to have the best fit. The AIC for these three models was estimated as of 47.91, 49.35 and 51.3 respectively, indicating the best fit for ARIMA (0, 1, 1) model. Results of the Ljung-Box test showed that after ACF first lag, other residuals were not excluded from the mean area and also the Ljung-Box test statistic was within the confidence interval indicating that there is no concern about the correlation of the residuals. ARIMA (0, 1, 1) model was applied for forecasting the time series until 2021.The predicted monthly mean (95% confidence interval) number of patients with poisoning referred to the hospitals during 2016-2021 was estimated as of 58.2.


In this study, the trend of referrals of patients with poisoning (opium, stimulants and alcohol) in the selected Iranian hospitals during 2011-2015 were investigated and also predicted up to 2021. The results showed an increasing trend which will continue if suitable interventions are not implemented. Control of diseases is one of the main goals of surveillance systems and reducing the prevalence of addiction can be suitable for limiting the burden of trauma [10]. The estimated increased trend of referral cases due to poisoning is parallel to the estimated increase of the prevalence of marijuana in the study carried out by Yuodelis-Flores and Ries, which showed that the prevalence of marijuana will increase from 1% in 2006 to 2.9% in 2020, and also number of illegal drug users will increase from 719,000 to 3.3 million persons [12].
Focusing on illegal drug use is one of the most important goals of the global burden of diseases (DALYs, Disability Adjusted Life Year) [13]. In a study carried out in 2003 in Iran, drug abuse attributed to the 510,000 deaths, which was the third cause of the main disease burden in men [14, 15]. The recent surveys showed that prevalence of drug abuse in Iran is more than the global mean [16]. In other words, drug associated mortalities was responsible for two-thirds of the suicides [10]. Similarly, our study showed an increasing trend for the patients with drug poisoning referred to the studied hospitals during 2011-2015. Benzodiazepines, methadone, tramadol, morphine and codeine are among the chemical drugs used extensively for treatment of withdrawal symptoms, anxiety, insomnia, epilepsy and muscular spasm [17-19]. Use of these drugs without prescription can lead to adverse effects and hospitalisation and also increasing the health costs in the community [17]. Tramadol related mortality is increasing in Iran especially among opium users [20]. In addition, tramadol toxicity is a great concern particularly among children in Iran [21]. Moreover, because of high prevalence of oral and inhaled impure opium (lead impurity) consumption in Iran, many patients are being referred to the hospital with chronic lead poisoning [22].
Although alcohol consumption is legally and culturally banned in Iran [23] and limited information is available regarding the alcohol abuse, recent reports showed that the use of this substance is increasing. Iran is the most prevalent area in the Middle East for methanol poisoning [24]. Therefore it has been recommended that in the case of any alcohol poisoning all other users were identified for any prophylactic interventions in order to reduce any probable poisoning and mortality. Methamphetamine use is a new health problem in this most populous Persian Gulf region country [25]. This kind of poisoning has many adverse consequences and there are many cases with cardiac arrest, convulsions, hallucinations, delusion, hypertension, unconsciousness, stroke and paraplegia that have been referred to the hospitals during the recent years [25]. Results of the current study may not be generalisable to the whole population affected by opium. Firstly because of the limited information about alcohol consumption in Iran [23, 24] and secondly the classified police and national registry database information has not been used in this study. Janssen investigated the official reported information of deaths due to smoking and alcohol consumption in France and found considerable underestimation. However, evaluating the hidden information revealed 30% increase in the overuse of these substances in the recent decade in that country [26]. Also we could not investigate the trend of referral rates based on some factors like age and gender due to lack of enough available information.
The present study responds to governmental concerns about mortality due to drug poisoning by suggesting the implementation of programmes like prevention of late intervention for referring and treatment of patients with poisoning. Naloxone is an FDA approved drug with appropriate effectiveness which can improve the symptoms of opium poisoning and reduce mortality [27-30]. Opium overdose preventive programme includes training activities about two main subjects: diagnosis of signs and symptoms of opium poisoning and type of response to poisoning such as naloxone therapy to prevent complications. This programme has been successfully implemented in several countries and training programmes have been carried out among families, emergency staff and police officers [31-34]. These programmes contribute to the reduction of referrals following poisoning events.
It should be noted that the frequency of drug poisoning referrals to the hospitals varied a lot with different months of each year. For example, it was zero in one month in a hospital while considerable cases were reported for that time in another hospital. In total, the lowest frequency was reported for December. No regular trend or seasonal pattern was observed for drug poisoning. One of the limitations can be due to the low quality of registry of the information in different hospitals in different years. Variation of recorder staff, burden of the referrals, having appropriate protocols for registry can be factors contributing to the quality of information. In addition, the small size of the studied community is another limitation that can be resolved by national level studies.


Our study revealed an increasing trend of patients referrals to the hospitals due to drug poisoning and our modelling predicted its continuation in 2021 if no appropriate interventions are considered. Comprehensive policymaking in Iran is recommended to reduce the burden of drug poisoning in the near future.

Conflict of interest

None declared./Nie występuje.

Financial support

None declared./Nie zadeklarowano.


The work described in this article has been carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) on medical research involving human subjects, Uniform Requirements for manuscripts submitted to biomedical journals and the ethical principles defined in the Farmington Consensus of 1997.
Treści przedstawione w pracy są zgodne z zasadami Deklaracji Helsińskiej odnoszącymi się do badań z udziałem ludzi, ujednoliconymi wymaganiami dla czasopism biomedycznych oraz zasadami etycznymi określonymi w Porozumieniu z Farmington w 1997 r.


1. Wickramatilake S, Zur J, Mulvaney-Day N, Campopiano von Klimo M, Selmi E, Harwood H. How states are tackling the opioid crisis. Public Health Reports 2017; 132(2): 171-9.
2. Ghane T, Zamani N, Hassanian-Moghaddam H, Beyrami A, Noroozi A. Lead poisoning outbreak among opium users in the Islamic Republic of Iran, 2016-2017. Bull World Health Organ 2018; 96(3): 165.
3. Amin‐Esmaeili M, Rahimi‐Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction 2016; 111(10): 1836-47.
4. Najjari FAM. Deaths Due to Poisoning Referred to Legal Medicine Organization of Iran. Medical Journal of the Islamic Republic of Iran 2003; 11(40): 309-18.
5. Ghanbari B, Malakouti SK, Nojomi M, De Leo D, Saeed K. Alcohol abuse and suicide attempt in Iran: a case-crossover study. Glob J Health Sci 2016; 8(7): 58-67.
6. Nikfarjam A, Hajimaghsoudi S, Rastegari A, Haghdoost AA, Nasehi AA, Memaryan N, et al. The frequency of alcohol use in Iranian urban population: the results of a national network scale up survey. Int J Health Policy Manag 2017; 6(2): 97-102.
7. Momtazi S, Rawson R. Substance abuse among Iranian high school students. Curr Opin Psychiatry 2010; 23(3): 221-6.
8. Jalali A, Hasan Rahmani A, Moosavi M, Mehrabi L, Saki A, Rowan EG. A Review of Acute Opiate Poisoning in the South West of Iran. J Drug Discov Develop Deliv 2017; 4(1): 1026.
9. White AM, Hingson RW, Pan IJ, Yi HY. Hospitalizations for alcohol and drug overdoses in young adults ages 18-24 in the United States, 1999-2008: results from the Nationwide Inpatient Sample. J Stud Alcohol Drugs 2011; 72(5): 774-86.
10. Najjari F, Afshar M. Deaths Due to Poisoning Referred to Legal Medicine Organization of Iran. Razi Journal of Medical Sciences 2004; 11(40): 309-16.
11. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. International classification of diseases 10th revision. 1992.
12. Yuodelis-Flores C, Ries RK. Addiction and Suicide: A Review. Am J Addict 2015; 24: 98-104.
13. Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382(9904): 1564-74.
14. Naghavi M, Abolhassani F, Pourmalek F, Lakeh MM, Jafari N, Vaseghi S, et al. The burden of disease and injury in Iran 2003. Population Health Metrics 2009; 7(1): 9.
15. Naserbakht M, Djalalinia S, Tayefi B, Gholami M, Ardabili ME, Shariat SV, et al. National and sub-national prevalence, trend, and burden of mental disorders and substance abuse in Iran: 1990-2013,study protocol. Arch Iran Med 2014; 17(3): 182-8.
16. Meibodi MK, Esfandyari S, Siyabi V, Roosta S. Illicit drug abuse in drivers of motor vehicle collisions. Galen Medical Journal 2015; 4(1): 39-46.
17. Liu Y, Cai J, Hoff GL, Hong L, Okah FA. Demographic risk factors affecting emergency room visits caused by benzodiazepine poisoning in Kansas City, Missouri, from 2001 to 2007. International Journal of Pharmacy Practice 2011; 19(3): 166-70.
18. Babakhanian M, Sadeghi M, Mansoori N, Mehrjerdi ZA, Tabatabai M. Nonmedical abuse of benzodiazepines in opiate-dependent patients in Tehran, Iran. Iran J Psychiatry Behav Sci 2012; 6(1): 62-7.
19. Allameh Y, Akrami FS, Mohammadi G, Molavi N, Babakhanian M. Methadone Poisoning in Children: A Systematic Review and Meta-Analysis in Iran. J Pediatric Rev 2017; 5(2): 1-8.
20. Iravani FS, Akhgari M, Jokar F, Bahmanabadi L. Current trends in tramadol-related fatalities, Tehran, Iran 2005-2008. Subst Use Misuse 2010; 45 (13): 2162-71.
21. Hassanian-Moghaddam H, Farnaghi F, Rahimi M. Tramadol overdose and apnea in hospitalized children, a review of 20 cases. Res Pharm Sci 2015; 10(6): 544-52.
22. Hayatbakhsh MM, Oghabian Z, Conlon E, Nakhaee S, Amirabadizadeh AR, Zahedi MJ, et al. Lead poisoning among opium users in Iran: an emerging health hazard. Subst Abuse Treat Prev Policy 2017; 12(1): 43.
23. Shadloo B, Motevalian A, Rahimi-Movaghar V, Amin-Esmaeili M, Sharifi V, Hajebi A, et al. Psychiatric disorders are associated with an increased risk of injuries: data from the Iranian Mental Health Survey (IranMHS). Iranian J Public Health 2016; 45(5): 623.
24. Hassanian-Moghaddam H, Zamani N. A Brief Review on Toxic Alcohols: Management Strategies. Iran J Kidney Dis 2016; 10(6): 344-50.
25. Alam-mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: a systematic review from the most populated Persian Gulf country. Asian J Psychiatr 2015; 16: 17-25.
26. Janssen E. Drug related deaths in France. A critical view. Revue d’epidemiologie et de sante publique 2009; 57(2): 126-9.
27. Buajordet I, Naess AC, Jacobsen D, Brors O. Adverse events after naloxone treatment of episodes of suspected acuteopioid overdose. Eur J Emerge Med 2004; 11(1): 19-23.
28. Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J 2005; 22(9): 612-6.
29. Dahan A, Aarts L, Smith TW. Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression. Anesthesiology 2010; 112(1): 226-38.
30. Boyer EW. Management of opioid analgesic overdose. N Engl J Med 2012; 367(2): 146-55.
31. Williams AV, Strang J, Marsden J. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug Alcohol Depend 2013; 132(1-2): 383-6.
32. Purviance D, Ray B, Tracy A, Southard E. Law enforcement attitudes towards naloxone following opioid overdose training. Subst Abuse 2017; 38(2): 177-82.
33. Ray B, O’Donnell D, Kahre K. Police officer attitudes towards intranasal naloxone training. Drug Alcohol Depend 2015; 146: 107-10.
34. Williams AV, Marsden J, Strang J. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes. Addiction 2014; 109(2): 250-9.
This is an Open Access journal distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), allowing third parties to download and share its works but not commercially purposes or to create derivative works.
© 2024 Termedia Sp. z o.o.
Developed by Bentus.